Secondary pseudotumour cerebri in a patient undergoing sexual reassignment therapy.
Mowl
Ashley D
AD
Indiana University, School of Optometry, Bloomington, Indiana 47405, USA.
Grogg
Jane Ann
JA
Klein
Judith
J
D000086:Acetazolamide / Q000627:therapeutic use; D000728:Androgens / Q000008:administration & dosage / Q000009:adverse effects*; D004232:Diuretics / Q000627:therapeutic use; D004334:Drug Administration Schedule; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D011559:Pseudotumor Cerebri / Q000139:chemically induced* / Q000188:drug therapy; D013739:Testosterone / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D014189:Transsexualism / Q000628:therapy*; D055815:Young Adult
D000728:Androgens; D004232:Diuretics; D013739:Testosterone; C016131:testosterone 17 beta-cypionate; D000086:Acetazolamide